CleanSpark, Inc.
CleanSpark, Inc. (CLSKW) Financial Performance & Income Statement Overview
Review CleanSpark, Inc. (CLSKW) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
CleanSpark, Inc. (CLSKW) Income Statement & Financial Overview
View the income breakdown for CleanSpark, Inc. CLSKW across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $162.31M | $89.28M | $104.11M | $104.11M |
| Cost of Revenue | $91.16M | $81.95M | $62.33M | $62.33M |
| Gross Profit | $71.15M | $7.33M | $41.78M | $41.78M |
| Gross Profit Ratio | $0.44 | $0.08 | $0.40 | $0.40 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $13.94M | $15.78M | $12.60M | $25.85M |
| Operating Expenses | -$138.83M | $72.93M | $290.86M | -$59.62M |
| Total Costs & Expenses | -$47.67M | $154.87M | $353.19M | -$25.32M |
| Interest Income | $1.48M | $1.48M | $2.64M | $2.68M |
| Interest Expense | $1.56M | $1.56M | $485000.00 | $485000.00 |
| Depreciation & Amortization | $78.90M | $51.85M | $51.85M | $40.73M |
| EBITDA | $323.80M | $323.80M | -$9.59M | -$204.53M |
| EBITDA Ratio | $1.99 | $3.63 | -$0.09 | -$1.96 |
| Operating Income | $209.98M | -$65.60M | -$65.60M | $137.12M |
| Operating Income Ratio | $1.29 | -$0.73 | -$0.63 | $1.32 |
| Other Income/Expenses (Net) | $46.03M | $46.03M | $3.26M | $3.34M |
| Income Before Tax | $256.008M | $256.008M | -$62.33M | -$245.74M |
| Income Before Tax Ratio | $1.58 | $2.87 | -$0.60 | -$2.36 |
| Income Tax Expense | $9.22M | $9.22M | -$155000.00 | -$9.49M |
| Net Income | $246.79M | $246.79M | -$62.18M | -$236.24M |
| Net Income Ratio | $1.52 | $2.76 | -$0.60 | -$2.27 |
| EPS | $0.85 | -$0.23 | -$1.03 | $0.59 |
| Diluted EPS | $0.83 | -$0.23 | -$1.03 | $0.58 |
| Weighted Avg Shares Outstanding | $284.55M | $284.55M | $228.64M | $228.64M |
| Weighted Avg Shares Outstanding (Diluted) | $291.89M | $291.89M | $228.64M | $228.64M |
Over the past four quarters, CleanSpark, Inc. demonstrated steady revenue growth, increasing from $104.11M in Q2 2024 to $162.31M in Q1 2025. Operating income reached $209.98M in Q1 2025, maintaining a consistent 129% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $323.80M, reflecting operational efficiency. Net income rose to $246.79M, with EPS at $0.85. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan